Fondation Apicil   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Lyon France (2004)

Organization Overview

First Clinical Trial
2009
NCT01194843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Fondation Apicil

Active Ingredients

Drugs in Phase 4 Trials (2)

morphine (1 trial)

sufentanil (1 trial)

Drugs in Phase 3 Trials (4)

desflurane (suprane) (1 trial)

ketamine (ketalar) (1 trial)

midazolam (versed) (1 trial)

remifentanil (ultiva) (1 trial)

Drugs in Phase 2 Trials (3)

ethosuximide (zarontin) (1 trial)

nitrous oxide (1 trial)

oxygen (1 trial)

Drugs in Other Trials (2)

ropivacaine (naropin) (1 trial)

serum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 3)

Colic (Phase 2)

Emergencies (Phase 4)

Inflammation (Phase 3)

Neuralgia (Phase 3)

Pain, Postoperative (Phase 3)

Renal Colic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 11